Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits.
about
Neuronal Nitric Oxide Synthase in Vascular Physiology and DiseasesEffects of BM-573 on Endothelial Dependent Relaxation and Increased Blood Pressure at Early Stages of AtherosclerosisEndothelial nitric oxide synthase in the microcirculation.The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.Current, new and future treatments in dyslipidaemia and atherosclerosis.Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension.Antithrombotic strategies in gene therapy.Gene therapy in cardiovascular disease. Current status.Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.Gene therapy for all aspects of vein-graft disease.Applied gene therapy in preclinical models of vascular injury.Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis.Anti-inflammatory strategies in hypertension: focus on COX-1 and COX-2.Overexpression of endothelial nitric oxide synthase improves endothelium-dependent vasodilation in arteries infused with helper-dependent adenovirus.Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function.Oxidative stress as a mediator of cardiovascular disease.Endothelium--role in regulation of coagulation and inflammation.Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.Atherosclerotic cardiovascular disease: a review of initiators and protective factors.Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo.Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide.nNOS gene transfer to RVLM improves baroreflex function in rats with chronic heart failure.Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis.Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice.Molecular analysis of cocaine-induced endothelial dysfunction: role of endothelin-1 and nitric oxide.Gene therapy for atherosclerosis and atherosclerosis-related diseases.Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism.Effect of binge cocaine treatment on hindlimb vascular function.Genetic and Pharmacological Modulation of Akt1 for Improving Ovarian Graft Revascularization in a Mouse Model.Lack of association between eNOS gene polymorphisms and ischemic heart disease in the Spanish population.
P2860
Q26745553-FF58A779-A895-4E8D-944B-A2BA69001602Q27315993-F7C49425-90D1-41E8-A324-51FE0086D8A2Q30278654-D645871A-83A4-4F3D-BEF1-F163ADA344A7Q33688733-51599BE5-1C83-4962-BDF9-91189442B4D5Q33993678-B857B60A-FAFF-4350-A863-76C2FA4A21FDQ34013918-D6C0D654-4F0E-4149-910E-D5EB49B90F25Q34027383-60CD4867-01E8-4BCE-B7B4-821675EA7BF1Q34782012-38228F31-94C4-4570-B2C6-B88BC83D2427Q34794990-C16274F3-88A7-4114-801D-DB2BD757894DQ35087837-5996A547-F4AF-4F76-954D-F9439F82C4FEQ35095408-B9AA29E8-8460-4A86-BF0D-4631178294D5Q35572369-FD21B579-7F0B-43A2-A0E6-9FE520155E1BQ35801877-E2F35A05-FF89-497B-B7AF-331C1D8986E3Q36025935-D33BF6A8-C9AF-4911-83E9-65BFC15912B3Q36401348-616603D6-F682-4105-B99B-07988F7E26E5Q37306295-51249833-13D2-4E16-94E6-A0D83936C003Q37780644-FF98400F-F6FD-45C2-BE53-AEEA9882D33BQ37918456-04F4B15D-DC37-410F-9201-9EBFBBBF7726Q38115527-6B22438D-2C92-43F0-98FC-F3039D9957BBQ38124049-BC7E1C8F-6ADD-460A-98A8-B5D4F0F82FD1Q38691756-62B873C0-17AB-4CDC-958D-1AB04297A629Q40730346-498DA922-4267-4AC7-955C-7C2572AED592Q44167880-540B8839-AA94-4BAF-AA55-3F4E25B94C00Q44582174-DF46CC42-3EE5-4811-B14E-266E7F972283Q44690690-2B04F178-97AC-4EBC-8367-9F2F407086AFQ45172377-D4069B99-DFD2-4CDB-A12A-A60929BCA388Q45760053-982E871D-474A-49CE-BE90-957FC430D046Q45873371-7C9DA6D3-5C65-4599-B405-43459014E3C4Q45881879-73CD6DE6-0B12-43D1-9DE4-CFC8E46F3BBDQ46643586-7893C501-5ED0-483A-BC32-12F350F11750Q53303647-136A370A-3F25-473F-BD6C-6212F0187980Q54798103-79905F7C-D195-49EA-AB83-6FBA55BBD72F
P2860
Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Nitric oxide synthase gene the ...... es of cholesterol-fed rabbits.
@en
Nitric oxide synthase gene the ...... es of cholesterol-fed rabbits.
@nl
type
label
Nitric oxide synthase gene the ...... es of cholesterol-fed rabbits.
@en
Nitric oxide synthase gene the ...... es of cholesterol-fed rabbits.
@nl
prefLabel
Nitric oxide synthase gene the ...... es of cholesterol-fed rabbits.
@en
Nitric oxide synthase gene the ...... es of cholesterol-fed rabbits.
@nl
P2093
P1433
P1476
Nitric oxide synthase gene the ...... es of cholesterol-fed rabbits.
@en
P2093
P304
P356
10.1161/01.CIR.99.23.2979
P407
P577
1999-06-01T00:00:00Z